Business article - July 24, 2026
BII announces new initiative to accelerate drug discovery for cardiometabolic diseases
The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for cardiometabolic diseases (CMDs).
Business article - June 29, 2026
“Our goal is to build a European framework that matches our scientific excellence with competitive financing capacity”
NLS asked Cedric Moreau, Chair of the Oversight Committee of the European Life Sciences Coalition (ELSC) and Partner at VC firm Sofinnova Partners, about the future of life sciences innovation and investment in Europe.
Business article - June 29, 2026
Open letter from ELSC calling on EU leaders to make life sciences a strategic priority
The newly formed European Life Sciences Coalition (ELSC) has sent an open letter to leading decision-makers and politicians in the EU and Sweden, urging them to take action.
Business article - June 29, 2026
In focus: Europe at a crossroads
Scientific excellence in a fragmented market means Europe will either lead or fall behind in global biotech.
Acquisition - June 26, 2026
Flerie and Biosergen have agreed on a merger plan
The Board of Directors of Flerie and the Board of Directors of Biosergen have adopted a plan to join forces through a statutory merger between the companies in accordance with the Swedish Companies Act.
Business article - June 24, 2026
New Nordic women’s health project
A newly approved EUR 2.8 million project will, over the next three years, bring together leading organizations from Sweden, Denmark and Norway to accelerate commercialization, investment and market access for companies developing solutions in women's health.
